Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02913612
Recruitment Status : Completed
First Posted : September 26, 2016
Last Update Posted : May 14, 2020
Sponsor:
Collaborators:
The Emmes Company, LLC
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Kanecia Zimmerman, MD MPH, Duke University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 28, 2020
Actual Study Completion Date : April 28, 2020